Peptide deformylase and LuxS as novel antibacterial drug targets

被引：0
作者：
Pei, DH [1 ]
机构：
[1] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2005年 / 230卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
72-BIOL
引用
收藏
页码：U536 / U537
页数：2
相关论文
共 50 条
  • [31] Peptide deformylase as an antibacterial drug target:: Assays for detection of its inhibition in Escherichia coli cell homogenates and intact cells
    Apfel, CM
    Evers, S
    Hubschwerlen, C
    Pirson, W
    Page, MGP
    Keck, W
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (04) : 1053 - 1057
  • [32] A practical enantioselective synthesis of a novel peptide deformylase inhibitor
    Slade, J
    Parker, D
    Girgis, M
    Mueller, M
    Vivelo, J
    Liu, H
    Bajwa, J
    Chen, GP
    Carosi, J
    Lee, P
    Chaudhary, A
    Wambser, D
    Prasad, K
    Bracken, K
    Dean, K
    Boehnke, H
    Repic, J
    Blacklock, TJ
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2006, 10 (01) : 78 - 93
  • [33] Novel non-peptidic inhibitors of peptide deformylase
    Kendall, AC
    Jayasekera, MMK
    Dermyer, MR
    Shammas, R
    Tomala, R
    Shapiro, MA
    Holler, TP
    [J]. FASEB JOURNAL, 2001, 15 (04) : A537 - A537
  • [34] Targeting the Peptide Deformylase of Mycobacterium tuberculosis Leads to Drug Discovery
    Singh, Vijai
    Somvanshi, Pallavi
    [J]. LETTERS IN DRUG DESIGN & DISCOVERY, 2009, 6 (07) : 487 - 493
  • [35] Riboswitches as antibacterial drug targets
    Kenneth F Blount
    Ronald R Breaker
    [J]. Nature Biotechnology, 2006, 24 : 1558 - 1564
  • [36] Riboswitches as antibacterial drug targets
    Blount, Kenneth F.
    Breaker, Ronald R.
    [J]. NATURE BIOTECHNOLOGY, 2006, 24 (12) : 1558 - 1564
  • [37] New peptide deformylase inhibitors and cooperative interaction: a combination to improve antibacterial activity
    Goemaere, Emilie
    Melet, Armelle
    Larue, Valery
    Lieutaud, Aurelie
    de Sousa, Rodolphe Alves
    Chevalier, Jacqueline
    Yimga-Djapa, Liselotte
    Giglione, Carmela
    Huguet, Florian
    Alimi, Mickael
    Meinnel, Thierry
    Dardel, Frederic
    Artaud, Isabelle
    Pages, Jean-Marie
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (06) : 1392 - 1400
  • [38] Novel peptidomimetic peptide deformylase (PDF) inhibitors ofMycobacterium tuberculosis
    Gokhale, Kunal M.
    Telvekar, Vikas N.
    [J]. CHEMICAL BIOLOGY & DRUG DESIGN, 2021, 97 (01) : 148 - 156
  • [39] Design, synthesis, and antibacterial activity of 2,5-dihydropyrrole formyl hydroxyamino derivatives as novel peptide deformylase inhibitors
    Shi, Wei
    Duan, Yuejiao
    Qian, Yu
    Li, Ming
    Yang, Liping
    Hu, Wenhao
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (12) : 3592 - 3595
  • [40] The Type III Secretion System as a Source of Novel Antibacterial Drug Targets
    Kline, Toni
    Felise, Heather B.
    Sanowar, Sarah
    Miller, Samuel I.
    [J]. CURRENT DRUG TARGETS, 2012, 13 (03) : 338 - 351
12345